- Record: found
- Abstract: not found
- Article: not found
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz, Steven M Hollenberg, JoAnn Lindenfeld, Frederick A Masoudi, Patrick E McBride, Pamela N Peterson, Lynne Warner Stevenson, Cheryl Westlake
2017-08-08
AHA Scientific Statements, hypertension, angiotensin receptor blockers, ferric carboxymaltose, heart failure, ivabradine, sleep apnea, natriuretic peptide biomarker, iron deficiency, angiotensin receptor-neprilysin inhibitor, focused update, angioedema, beta blockers, natriuretic peptides, angiotensin-converting enzyme inhibitors
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
AHA Scientific Statements,hypertension,angiotensin receptor blockers,ferric carboxymaltose,heart failure,ivabradine,sleep apnea,natriuretic peptide biomarker,iron deficiency,angiotensin receptor-neprilysin inhibitor,focused update,angioedema,beta blockers,natriuretic peptides,angiotensin-converting enzyme inhibitors
AHA Scientific Statements, hypertension, angiotensin receptor blockers, ferric carboxymaltose, heart failure, ivabradine, sleep apnea, natriuretic peptide biomarker, iron deficiency, angiotensin receptor-neprilysin inhibitor, focused update, angioedema, beta blockers, natriuretic peptides, angiotensin-converting enzyme inhibitors
Comments
Comment on this article
scite_